Mannkind (MNKD) Retained Earnings (2010 - 2026)
Mannkind (MNKD) reported Retained Earnings of -$3.2 billion for Q1 2026, down 0.75% year-over-year from -$3.2 billion in Q1 2025, and down 0.52% quarter-over-quarter from -$3.2 billion in Q4 2025.
Mannkind (MNKD) Retained Earnings (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Retained Earnings data on file, last reported at -$3.2 billion in Q1 2026.
- Retained Earnings for Q1 2026 came in at -$3.2 billion, down 0.75% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.2 billion (down 0.75% YoY), and the FY2025 annual result was -$3.2 billion, changed 0.18% from the prior year.
- Retained Earnings slipped to -$3.2 billion in Q1 2026 per MNKD's latest filing, from -$3.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $588000.0 in Q3 2024 and troughed at -$3.2 billion in Q4 2023.
- A 5-year average of -$2.5 billion and a median of -$3.2 billion in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings surged 100.01% in 2023, then slumped 727140.86% in 2024.
- A 5-year view of Retained Earnings shows it stood at -$3.2 billion in 2022, then declined by 0.37% to -$3.2 billion in 2023, then increased by 0.85% to -$3.2 billion in 2024, then climbed by 0.18% to -$3.2 billion in 2025, then dropped by 0.52% to -$3.2 billion in 2026.
- Business Quant data shows MNKD's Retained Earnings at -$3.2 billion in Q1 2026, -$3.2 billion in Q4 2025, and -$3.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | -3.21 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.21 Bn |
| Dec 31, 2025 | -3.20 Bn |
| Sep 30, 2025 | -3.18 Bn |
| Jun 30, 2025 | -3.19 Bn |
| Mar 31, 2025 | -3.19 Bn |
| Dec 31, 2024 | -3.20 Bn |
| Sep 30, 2024 | 588,000.00 |
| Jun 30, 2024 | -3.22 Bn |
| Mar 31, 2024 | -3.22 Bn |
| Dec 31, 2023 | -3.23 Bn |
| Sep 30, 2023 | 443,000.00 |
| Jun 30, 2023 | 443,000.00 |
| Mar 31, 2023 | -3.23 Bn |
| Dec 31, 2022 | -3.22 Bn |
| Sep 30, 2022 | -3.20 Bn |
| Jun 30, 2022 | -3.19 Bn |
| Mar 31, 2022 | -1.08 Mn |
| Dec 31, 2021 | -3.13 Bn |
| Sep 30, 2021 | -3.10 Bn |
| Jun 30, 2021 | -3.10 Bn |